Loading...

Human TruStain FcX™ (Fc Receptor Blocking Solution)

Pricing & Availability
Regulatory Status
RUO
Other Names
Fc Blocker, FcγR blocker, Fc inhibitor
Ave. Rating
Submit a Review
Product Citations
publications
A_Human_TruStain_FcX_031110
Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant rat IgG2b PE mAb (above). Dotted histogram represents unstained cells.
  • C_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (filled histograms) or non-treated (open histograms) THP-1 cells stained with anti-human HLA-DR PE (red) or an isotype control (IgG2a PE, blue) mAbs. Note: non-treated cells show false-negative HLA-DR staining due to high binding of mouse IgG2a isotype.
Cat # Size Price Quantity Check Availability Save
422301 50 tests £70
Check Availability


Need larger quantities of this item?
Request Bulk Quote
422302 200 tests £157
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Human Fc receptors (FcRs) are expressed on a variety of cells, such as monocytes, granulocytes, B cells and dendritic cells. The cells with FcR expression sometimes give false positive or false negative results of immunofluorescent staining due to the FcRs-mediated Ig Fc binding. Human TruStain FcX™ is specially formulated for blocking the FcR-involved unwanted staining without interfering with antibody-mediated specific staining of human cells. Human TruStain FcX™ is compatible with flow cytometric staining with anti-human CD16 (clone 3G8), CD32 (clone FUN-2), and CD64 (clone 10.1) antibodies.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
Store between 2°C and 8°C.
Application

FC - Quality tested
ICFC, ICC - Reported in the literature, not verified in house
Recommended Usage

It is recommended to add 5 µl of Human TruStain FcX™ per million cells in 100 µl staining volume, mix and incubate at room temperature for 5-10 minutes prior to staining with antibody of interest. It is not necessary to wash cells between these blocking and immunostaining steps.

Application Notes

This buffer contains specialized human IgG in PBS containing 0.09% sodium azide. It is not recommended to be used for staining human IgG. Handle as biohazard agent.

Application References

(PubMed link indicates BioLegend citation)
  1. de la Cruz J, et al. 2011. J. Immunol. 186:2282. PubMed
  2. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  3. Szerlip NJ, et al. 2012. PNAS. 109:3041. PubMed
  4. Bromley SK, et al. 2013. J. Immunol. 190:970. PubMed
  5. Trujilo G, et al. 2013. J. Immunol. 191:848. PubMed
  6. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  7. Euzebio Alves VT, et al. 2013. Infect Immun. 81:4399. PubMed
  8. Borg ZD, et al. 2014. J. Immunol. 192:189. PubMed
  9. Klingenberg R, et al. 2014. Eur Heart J. PubMed
  10. Lines JL, et al. 2014. Cancer Res. 74:1924. PubMed
  11. Decker D, et al. 2014. Lupus. 23:802. PubMed
  12. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  13. Anderson ME Jr, et al. 2014. Otolaryngol Head Neck Surg. 150:880. PubMed
  14. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  15. Shi J, et al. 2014. Blood. 123:4015. PubMed
  16. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  17. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  18. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  19. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  20. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  21. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  22. Vuong TT, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  23. Klingenberg R, et al. 2015. Eur Heart J. 36:1041. PubMed
  24. Wilkinson-Ryan I, et al. 2015. PLoS One.10:125851. PubMed
Product Citations
  1. Klingenberg R, et al. 2014. Eur Heart J. . PubMed
  2. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  3. Simon A, et al. 2015. Blood. 126: 378 - 385. PubMed
  4. Mitton B, et al. 2016. Leukemia. 10.1038/leu.2016.139. PubMed
  5. Wanke F, et al. 2017. Cell Rep. 18(5):1270-1284. PubMed
  6. Ecker JW, et al. 2020. Vaccines (Basel). 8:00. PubMed
  7. Liu C, et al. 2021. Cell. 184(7):1836-1857.e22. PubMed
  8. Tsai AG, et al. 2020. Nat Med. 408:26. PubMed
  9. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  10. Chen X, et al. 2019. Exp Ther Med. 1.265972222. PubMed
  11. Fisher RC, et al. 2019. Neoplasia. 1.061805556. PubMed
  12. Winkler CW, et al. 2019. J Neuroinflammation. 0.825694444. PubMed
  13. O'Huallachain M, et al. 2020. Commun Biol. 3:213. PubMed
  14. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  15. Aguilar EG, et al. 2021. Blood Adv. 5:4219. PubMed
  16. Lambert E, et al. 2022. Acta Neuropathol Commun. 10:4. PubMed
  17. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  18. Ptacin JL, et al. 2021. Nat Commun. 12:4785. PubMed
  19. Lau D, et al. 2022. Nat Commun. 13:4053. PubMed
  20. Sipe CJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  21. Alber S, et al. 2022. Front Immunol. 13:838636. PubMed
  22. Friebel E, et al. 2020. Cell. 181(7):1626-1642.e20. PubMed
  23. Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed
  24. Biasci D, et al. 2020. Proc Natl Acad Sci U S A. 117:28960. PubMed
  25. Glass DR, et al. 2020. Immunity. 53:217. PubMed
  26. Jackson S, et al. 2016. J Exp Med. 213: 733 - 750. PubMed
  27. Shin J, et al. 2016. Sci Rep. 6:23426. PubMed
  28. Vuong T, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  29. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  30. Starlard–Davenport A, et al. 2019. Br J Haematol. 186:91. PubMed
  31. Wartewig T, et al. 2017. Nature. . 10.1038/nature24649. PubMed
  32. Mehta P, et al. 2021. J Immunol. 207:1763. PubMed
  33. Lam B, et al. 2021. Cell Rep. 37:109838. PubMed
  34. de Cevins C, et al. 2021. Med (N Y). 2:1072. PubMed
  35. Gouin KH, et al. 2021. Nat Commun. 12:4906. PubMed
  36. Stanzione M, et al. 2022. Sci Adv. 8:eabn1229. PubMed
  37. Yoshida M, et al. 2022. Nature. 602:321. PubMed
  38. Egnuni T, et al. 2021. Pharmaceutics. 13:. PubMed
  39. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  40. Jundi B, et al. 2021. JCI Insight. 6:e148866. PubMed
  41. Trujillo G, et al. 2013. J Immunol. 191:848. PubMed
  42. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  43. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  44. Nielsen CM, et al. 2021. Cell Reports Medicine. 2(3):100207. PubMed
  45. Goveia J, et al. 2020. Cancer Cell. 21:37. PubMed
  46. Raju R, et al. 2017. Stem Cells Dev. 26:274. PubMed
  47. Karagiannis TT, et al. 2020. Nat Commun. 2.271527778. PubMed
  48. Lee E, et al. 2021. Sci Rep. 11:14841. PubMed
  49. Doerflinger M, et al. 2021. Clin Transl Immunology. 10:e1235. PubMed
  50. Chen L, et al. 2021. Int J Mol Sci. 22:. PubMed
  51. Chen GM, et al. 2021. Cancer Discov. 11:2186. PubMed
  52. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  53. Rip J, et al. 2021. Bio Protoc. 11:e3902. PubMed
  54. Cluff E, et al. 2022. Cancer Immunol Immunother. . PubMed
  55. Mylka V, et al. 2022. Genome Biol. 23:55. PubMed
  56. Jairaman A, et al. 2022. Elife. 11:. PubMed
  57. Takano T, et al. 2022. Cell Rep Med. 3:100631. PubMed
  58. Vinjamur DS, et al. 2021. Nat Genet. 53:719. PubMed
  59. Judge SJ, et al. 2022. Front Immunol. 13:893177. PubMed
  60. Lo MW, et al. 2022. Clin Transl Immunology. 11:e1413. PubMed
  61. Masuda K, et al. 2022. JCI Insight. 7:. PubMed
  62. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  63. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  64. Gupta S, et al. 2020. Proc Natl Acad Sci U S A. 117:16481. PubMed
  65. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  66. Lindgren I, et al. 2016. Hum Reprod. 31: 672 - 683. PubMed
  67. Beljanski V, et al. 2015. J Virol. 89: 10612 - 10624. PubMed
  68. Pontarini E, et al. 2015. Rheumatology. 54: 1429-1434. PubMed
  69. Feng WW, et al. 2019. Cell Rep. 29:3405. PubMed
  70. Li Z, et al. 2018. Exp Ther Med. 3.410416667. PubMed
  71. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  72. Cook CP, et al. 2022. Cell Rep Med. 3:100715. PubMed
  73. Zhou WH, et al. 2022. Discov Oncol. 13:67. PubMed
  74. Wang M, et al. 2022. Immun Inflamm Dis. 10:e626. PubMed
  75. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  76. Pérez-Pérez S, et al. 2022. Biomedicines. 10:. PubMed
  77. Figueroa-Romero C, et al. 2022. Front Immunol. 13:773288. PubMed
  78. Chen X, et al. 2022. Front Immunol. 12:807134. PubMed
  79. Emmons TR, et al. 2021. Cancer Immunol Res. 9:790. PubMed
  80. Snyder ME, et al. 2021. Am J Respir Crit Care Med. 203:1230. PubMed
  81. Jama B, Morris G 2014. J Vis Exp. 93: 52257. PubMed
  82. Patera A, et al. 2016. J Leukoc Biol. 100(6):1239-1254. PubMed
  83. Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed
  84. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  85. Wang E, et al. 2021. Cell Stem Cell. 28(4):718-731.e6. PubMed
  86. Wright AKA, et al. 2017. J Allergy Clin Immunol. 140:1430. PubMed
  87. Al–Marsoummi S, et al. 2019. Cell Physiol Biochem. 53:999. PubMed
  88. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  89. Seamon K, et al. 2020. Front Immunol. 11:396. PubMed
  90. Harris MJ, et al. 2021. Mol Syst Biol. 17:e10091. PubMed
  91. Liu C, et al. 2021. Cell Res. 31:1106. PubMed
  92. Pickering H, et al. 2021. JCI Insight. 6:. PubMed
  93. Nugent JL, et al. 2021. iScience. 24:103421. PubMed
  94. Chen Z, et al. 2022. J Nanobiotechnology. 20:30. PubMed
  95. Ogbe A, et al. 2022. JCI Insight. . PubMed
  96. Sun V, et al. 2021. Front Immunol. 12:716661. PubMed
  97. Andrews JM, et al. 2021. EBioMedicine. 71:103559. PubMed
  98. Apostolidis SA, et al. 2022. Front Immunol. 13:834988. PubMed
  99. Woodruff MC, et al. 2022. Nature. :. PubMed
  100. Wang L, et al. 2022. Theranostics. 12:7216. PubMed
  101. Layer JV, et al. 2020. Proc Natl Acad Sci U S A. 27566:117. PubMed
  102. Dogra P, et al. 2020. Cell. 749:180. PubMed
  103. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  104. Linke M, et al. 2017. Nat Immunol. 18:293-302. PubMed
  105. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  106. Vir P, et al. 2015. PLoS One. 10: 0144904. PubMed
  107. Fuentes I, et al. 2020. Sci Rep. 10:15064. PubMed
  108. Stuart T, et al. 2019. Cell. 177:1888. PubMed
  109. Gao X, et al. 2017. PLoS One. 10.1371/journal.pone.0189167. PubMed
  110. Dashtsoodol N, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01206. PubMed
  111. Deng H, et al. 2017. Arthritis Res Ther. 10.1186/s13075-017-1339-4. PubMed
  112. Kumar V, et al. 2022. Cells. 11:. PubMed
  113. Burnett CE, et al. 2022. Immunity. 55:1284. PubMed
  114. Calianese D, et al. 2021. J Immunol. 207:436. PubMed
  115. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  116. Vijayakumar B, et al. 2022. Immunity. . PubMed
  117. Pérez-Pérez S, et al. 2021. Front Immunol. 12:798003. PubMed
  118. Chan JM, et al. 2021. Cancer Cell. 39:1479. PubMed
  119. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  120. Toulmin SA, et al. 2021. Nat Commun. 12:3993. PubMed
  121. Stephenson E, et al. 2021. Nat Med. 27:904. PubMed
  122. Decker D, et al. 2014. Lupus. 123:2663. PubMed
  123. Lisovsky I, et al. 2015. J Virol. 89: 9909 - 9919. PubMed
  124. Busch S, et al. 2016. J Immunol. 197(11):4493-4503. PubMed
  125. Bowen J, et al. 2017. PLoS Pathog. 13(2):e1006164. PubMed
  126. Kreutmair S, et al. 2021. Immunity. . PubMed
  127. Rapiteanu R, et al. 2020. Eur Respir J. :55. PubMed
  128. Harrison TE, et al. 2020. Nature. 309:587. PubMed
  129. Zhang W, et al. 2019. Exp Ther Med. 2.490972222. PubMed
  130. Bocharnikov AV, et al. 2019. JCI Insight. 4:e126832. PubMed
  131. Mair F, et al. 2020. Cell Rep. 31:107499. PubMed
  132. Poonpanichakul T, et al. 2021. Front Immunol. 12:599805. PubMed
  133. Sen K, et al. 2021. Front Immunol. 12:733539. PubMed
  134. Zheng S, et al. 2022. Blood Cancer Discov. 3:103. PubMed
  135. Quinn TM, et al. 2022. EBioMedicine. 76:103856. PubMed
  136. Vanshylla K, et al. 2022. Cell Host Microbe. 30:69. PubMed
  137. Worwa G, et al. 2022. Commun Biol. 5:1204. PubMed
  138. Qiu XM, et al. 2020. Reproduction. 251:159. PubMed
  139. Gonzalez VD, et al. 2021. Cell Reports. 36(9):109632. PubMed
  140. Obradovic A, et al. 2021. Cell. 184(11):2988-3005.e16. PubMed
  141. Russ K, et al. 2021. Cell Reports. 34(12):108895. PubMed
  142. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  143. Judge SJ, et al. 2020. J Clin Invest. 130:3051. PubMed
  144. Market M, et al. 2020. Front Immunol. 1.127083333. PubMed
  145. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  146. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  147. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  148. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  149. Abrecht C, et al. 2022. STAR Protoc. 3:101362. PubMed
  150. Lai ZZ, et al. 2020. Am J Reprod Immunol. 84:e13295. PubMed
  151. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  152. Romine KA, et al. 2021. Blood Cancer Discov. 2:518. PubMed
  153. Vanuytsel K, et al. 2022. Nat Commun. 13:1103. PubMed
  154. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  155. Muir LA, et al. 2022. JCI Insight. 7:. PubMed
  156. Romine KA, et al. 2021. Cancer Discov. . PubMed
  157. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  158. Shen Z, et al. 2021. iScience. 24:103014. PubMed
  159. Wu CL, et al. 2021. Nat Commun. 12:362. PubMed
  160. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  161. Borg Z, et al. 2014. J Immunol. 192:189. PubMed
  162. Shi J, et al. 2014. Blood. 123:4015. PubMed
  163. Galvani S, et al. 2015. Sci Signal. 8: ra79. PubMed
  164. Boyerinas B, et al. 2015. Cancer Immunol Res. 3: 1148 - 1157. PubMed
  165. Zabransky DJ, et al. 2015. Proc Natl Acad Sci U S A. 112: 6205 -6214. PubMed
  166. Thorek D, et al. 2016. Sci Transl Med. 8: 367ra167. PubMed
  167. Le BV, et al. 2020. Cell Rep. 33:108221. PubMed
  168. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  169. Lu Q, et al. 2021. Immunity. 54(6):1304-1319.e9. PubMed
  170. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  171. Helmink BA, et al. 2020. Nature. 577:549. PubMed
  172. Souriant S, et al. 2019. Cell Rep. 26:3586. PubMed
  173. Riordon DR, et al. 2017. Methods Mol Biol. 1722:127. PubMed
  174. Cao Y, et al. 2021. Cell Res. 31:732. PubMed
  175. Wang W, et al. 2021. Clin Transl Med. 11:e253. PubMed
  176. Wang YC, et al. 2021. Nat Commun. 12:3530. PubMed
  177. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  178. Painter MM, et al. 2021. Immunity. 54:2133. PubMed
  179. Syrimi E, et al. 2021. iScience. 24:103215. PubMed
  180. Thijssen R, et al. 2022. Blood. :. PubMed
  181. Good Z, et al. 2022. Nat Med. :. PubMed
  182. Ferrer-Font L, et al. 2021. Curr Protoc. 1:e222. PubMed
  183. Weaver JD, et al. 2022. Oncoimmunology. 11:2141007. PubMed
  184. Opzoomer JW, et al. 2021. Elife. :10. PubMed
  185. Woodruff M, et al. 2020. medRxiv. . PubMed
  186. Nabet BY, et al. 2020. Cell. 183(2):363-376.e13. PubMed
  187. Zobel MJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  188. Seifert L, et al. 2015. Cell Rep. 13: 1909-1921. PubMed
  189. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  190. Yoon J, et al. 2020. Front Cell Dev Biol. 0.520138889. PubMed
  191. Poon E, et al. 2017. J Immunother Cancer. 10.1186/s40425-017-0268-8. PubMed
  192. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  193. Chen Y, et al. 2022. Front Immunol. 13:835690. PubMed
  194. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  195. Jiang Y, et al. 2020. Br J Pharmacol. . PubMed
  196. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  197. Lundholm M, et al. 2015. Sci Rep. 5: 15651. PubMed
  198. Revelo X, et al. 2016. Cell Rep. 16: 717-730. PubMed
  199. Thomas K, et al. 2016. J Leukoc Biol. 100: 177 - 184. PubMed
  200. Burns JC, et al. 2020. eLife. 9:00. PubMed
  201. Herati RS, et al. 2021. Cell Reports Medicine. 2(5):100262. PubMed
  202. Ziegler CGK, et al. 2021. Cell. 184(18):4713-4733.e22. PubMed
  203. An Y, et al. 2021. Sci Rep. 6392:11. PubMed
  204. Zhu Y, et al. 2019. Cell Stem Cell. 25:542. PubMed
  205. Chen G, et al. 2021. Signal Transduct Target Ther. 6:289. PubMed
  206. Besnier M, et al. 2021. Antioxidants (Basel). 10:. PubMed
  207. Dugger DT, et al. 2021. Front Immunol. 12:704172. PubMed
  208. Vick SC, et al. 2021. Sci Adv. 7:eabj0274. PubMed
  209. Hu Y, et al. 2021. Am J Hum Genet. 108:874. PubMed
  210. Levi H, et al. 2022. J Exp Med. 219:. PubMed
  211. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  212. Trevelin SC, et al. 2022. Front Immunol. 13:838328. PubMed
  213. Sureshchandra S, et al. 2022. Cell Rep. 39:110938. PubMed
  214. Ndeupen S, et al. 2021. iScience. 24:103479. PubMed
  215. Zhu S, et al. 2022. J Oncol. 2022:8724933. PubMed
  216. Gadi D, et al. 2022. Leukemia. 36:723. PubMed
  217. Studniberg SI, et al. 2022. Mol Syst Biol. 18:e10824. PubMed
  218. Huang Y, et al. 2022. iScience. 25:105209. PubMed
  219. Quintanal-Villalonga A, et al. 2022. STAR Protoc. 3:101776. PubMed
  220. Liu Y, et al. 2022. Front Oncol. 12:1037934. PubMed
  221. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  222. OConnor RA, et al. 2021. OncoImmunology. 10(1):1940675. PubMed
  223. Cheng Y, et al. 2021. Immunity. 54(8):1825-1840.e7. PubMed
  224. Glassman CR, et al. 2021. Cell. 184(4):983-999.e24. PubMed
  225. Zeng J, et al. 2020. Nat Med. 26:535. PubMed
  226. Wang C, et al. 2015. Clin Immunol. 159: 47-57. PubMed
  227. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  228. Cruz J, et al. 2011. J Immunol. 186:2282. PubMed
  229. Reustle A, et al. 2022. Clin Transl Med. 12:e883. PubMed
  230. Bahcecioglu G, et al. 2021. Adv Sci (Weinh). 8:e2100128. PubMed
  231. Li G, et al. 2021. Curr Protoc. 1:e50. PubMed
  232. Anadon CM, et al. 2022. STAR Protoc. 3:101649. PubMed
  233. Nadeu F, et al. 2022. Nat Med. 28:1662. PubMed
  234. Hirschberger S, et al. 2022. Front Med (Lausanne). 9:923502. PubMed
  235. Pathania AS, et al. 2022. Mol Ther Oncolytics. 25:308. PubMed
  236. Wang J, et al. 2022. iScience. 25:103971. PubMed
  237. Wu Y, et al. 2022. J Cancer Res Clin Oncol. . PubMed
  238. Woolley CR, et al. 2022. Immunohorizons. 6:47. PubMed
  239. Wendisch D, et al. 2021. Cell. 184:6243. PubMed
  240. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  241. Poon MML, et al. 2021. Cell Rep. 37:110071. PubMed
  242. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  243. Wegner J, et al. 2021. Sci Rep. 11:14983. PubMed
  244. Sun L, et al. 2021. Sci Rep. 11:12477. PubMed
  245. Tsuboki J, et al. 2016. Sci Rep. 6:29588. PubMed
  246. Gao M, et al. 2016. Sci Rep. 6:29955. PubMed
  247. Stephanie Elizabeth, Johanna Zandee 2017. Immunol Cell Biol. 10.1038/icb.2017.3. PubMed
  248. Morales Pantoja IE, et al. 2020. PLoS One. 15:e0233980. PubMed
  249. Huetter J, et al. 2020. Cancer Immunol Res. 0.954861111. PubMed
  250. Still C 2nd, et al. 2021. Cell Reports Medicine. 2(7):100343. PubMed
  251. Feng W, et al. 2020. J Vis Exp. . PubMed
  252. Hannon E, et al. 2021. PLoS Genet. e1009443:17. PubMed
  253. Qin XH, et al. 2019. Langmuir. 35:1882. PubMed
  254. Song M, et al. 2018. Nature. 562:423. PubMed
  255. Good Z, et al. 2019. Nat Biotechnol. 37:259. PubMed
  256. Xue J, et al. 2020. Arthritis Res Ther. 1.070138889. PubMed
  257. Li YR, et al. 2021. Cell Rep Med. 2:100449. PubMed
  258. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  259. Kusi M, et al. 2022. Cell Rep. 38:110220. PubMed
  260. Dahal S, et al. 2022. Retrovirology. 19:18. PubMed
  261. Cortés-López M, et al. 2022. Nat Commun. 13:5570. PubMed
  262. LaSalle TJ, et al. 2022. Cell Rep Med. 3:100779. PubMed
  263. Larson-Casey JL, et al. 2020. PLoS One. 15:e0241323. PubMed
  264. Carmona-Rivera C, et al. 2020. JCI Insight. 5:00. PubMed
  265. Surendran N, et al. 2016. Innate Immunity. 22: 63 - 71. PubMed
  266. Lines J, et al. 2014. Cancer Res. 74:1924. PubMed
  267. Alves V, et al. 2013. Infect Immun . 81:4399. PubMed
  268. Ellyard JI, et al. 2019. Front Immunol. 1.898611111. PubMed
  269. Fan C, et al. 2019. Mol Med Rep. 3.002083333. PubMed
  270. Franco LM, et al. 2019. J Exp Med. 216:384. PubMed
  271. Oetjen KA, et al. 2018. JCI Insight. 3:e124928. PubMed
  272. Jiang X, et al. 2018. Cell Mol Immunol. 1.338194444. PubMed
  273. Gov L,et al. 2017. J Immunol. 10.4049/jimmunol.1700245. PubMed
  274. Metcalf T, et al. 2017. J Immunol. 10.4049/jimmunol.1700148. PubMed
  275. Huang D, et al. 2022. Cell Discov. 8:121. PubMed
  276. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  277. Michelozzi IM, et al. 2022. STAR Protoc. 3:101174. PubMed
  278. Lo YC, et al. 2022. Nat Commun. 13:934. PubMed
  279. Thakkar D, et al. 2022. J Immunother Cancer. 10:. PubMed
  280. Erickson JR, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  281. Wang X, et al. 2022. J Immunol. 208:396. PubMed
  282. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  283. Paul S, et al. 2021. Sci Transl Med. 13:. PubMed
  284. Combes AJ, et al. 2021. Nature. 591:124. PubMed
  285. Szerlip N, et al. 2012. Proc Natl Acad Sci U S A. 109:3041. PubMed
  286. Bromley S, et al. 2013. J Immunol. 190:970. PubMed
  287. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  288. Page K, et al. 2015. J Pharmacol Exp Ther. 355: 199 - 205. PubMed
  289. Wanke-Jellinek L, et al. 2016. J Immunol. 196: 767 - 777. PubMed
  290. Schneeberger V, et al. 2016. PLoS One. 11: 0160587. PubMed
  291. Maini A, et al. 2016. PLoS One. 11:e0165502. PubMed
  292. Burel J, et al. 2016. PLoS Negl Trop Dis. 10:e0005031. PubMed
  293. Kirabo A, et al. 2017. J Mol Cell Cardiol. 10.1016/j.yjmcc.2017.03.001. PubMed
  294. Judge SJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  295. Greenlee JD, et al. 2021. eLife. 0.416666666666667. PubMed
  296. Herland A, et al. 2020. Nat Biomed Eng. 421:4. PubMed
  297. Hepprich M, et al. 2020. Cell Metab. 699:31. PubMed
  298. Demaree B, et al. 2021. Nat Commun. 1583:12. PubMed
  299. Guo JJ, et al. 2017. Exp Ther Med. 3.842361111. PubMed
  300. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  301. Nobre LV, et al. 2020. eLife. 8:e49894.. PubMed
  302. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  303. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  304. Hirschberger S, et al. 2021. EMBO Mol Med. 13:e14323. PubMed
  305. Liao M, et al. 2021. Aging (Albany NY). 13:22412. PubMed
  306. Gutierrez C, et al. 2021. Nat Cancer. 2:758. PubMed
  307. Georg P, et al. 2022. Cell. 185:493. PubMed
  308. Céspedes PF, et al. 2022. Nat Commun. 13:3460. PubMed
  309. Zhang F, et al. 2021. Genome Med. 13:64. PubMed
  310. Luque-Martin R, et al. 2021. J Immunol. 207:555. PubMed
  311. Li F, et al. 2022. Nat Commun. 13:4334. PubMed
  312. Rydyznski Moderbacher C, et al. 2022. J Clin Invest. :. PubMed
  313. Hwang B, et al. 2021. Nat Methods. 18:903. PubMed
  314. Montel-Hagen A, et al. 2022. Curr Protoc. 2:e403. PubMed
  315. López-Sanz C, et al. 2022. STAR Protoc. 3:101755. PubMed
  316. Shuwa HA, et al. 2021. Med. 2(6):720-735.e4. PubMed
  317. Landgraf KE, et al. 2020. Commun Biol. 0.330555556. PubMed
  318. Nahid M, et al. 2016. J Leukoc Biol. 100: 339 - 349. PubMed
  319. Eichten A, et al. 2016. Cancer Res . 76: 2327-2339. PubMed
  320. Wierzbinska JA, et al. 2020. Genome Med. 12:29. PubMed
  321. Bricio–Moreno L, et al. 2018. Nat Commun. 2.204861111. PubMed
  322. Arrigucci R, et al. 2017. Nat Protoc. 1.364583333. PubMed
  323. Strazza M, et al. 2022. Mol Ther Methods Clin Dev. 27:380. PubMed
  324. Konkimalla A, et al. 2022. iScience. 25:105114. PubMed
  325. Tang JS, et al. 2022. Front Immunol. 13:946713. PubMed
  326. Liu Y, et al. 2022. Clin Transl Med. 12:e654. PubMed
  327. Ruan LY, et al. 2022. Biomolecules. 12:. PubMed
  328. Lederer K, et al. 2022. Cell. . PubMed
  329. Wang YM, et al. 2022. Oncoimmunology. 11:2034257. PubMed
  330. Jiang J, et al. 2021. Front Immunol. 12:785549. PubMed
  331. Yang Y, et al. 2021. Emerg Microbes Infect. 10:905. PubMed
  332. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  333. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  334. Wilkinson-Ryan I, et al. 2015. PLoS One. 10:125851. PubMed
  335. Ali A, et al. 2015. PLoS One. 10: 0131645. PubMed
  336. Kanzaki H, et al. 2016. Sci Rep. 6:32259. PubMed
  337. Goehring K, et al. 2016. J Nutr. 146(12):2559-2566. PubMed
  338. Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed
  339. Maehara T, et al. 2020. J Clin Invest. 130:2451. PubMed
  340. Mathewson ND, et al. 2021. Cell. 184(5):1281-1298.e26. PubMed
  341. Szodoray P, et al. 2021. Cell Reports. 36(6):109525. PubMed
  342. Jin HS, et al. 2020. Cancer Immunol Res. 8:912. PubMed
  343. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  344. Kubala MH, et al. 2018. Cell Rep. 25:2177. PubMed
  345. Wu X, et al. 2020. Front Immunol. 1.922222222. PubMed
  346. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  347. Rovira-Clavé X, et al. 2021. Nat Commun. 12:4628. PubMed
  348. Wurm M, et al. 2021. Mol Cancer Ther. 20:2250. PubMed
  349. Pauken CM, et al. 2021. Cancers (Basel). 13:. PubMed
  350. Genge PC, et al. 2021. STAR Protoc. 2:100900. PubMed
  351. Winkler C, et al. 2021. JCI Insight. 6:. PubMed
  352. Adamo S, et al. 2022. Nature. 602:148. PubMed
  353. Krijgsman D, et al. 2022. STAR Protoc. 3:101034. PubMed
  354. Hallisey M, et al. 2022. STAR Protoc. 3:101163. PubMed
  355. Konishi S, et al. 2022. STAR Protoc. 3:101447. PubMed
  356. Galván-Peña S, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  357. Wilson TL, et al. 2022. Cancer Discov. 12:2098. PubMed
  358. Claireaux MAF, et al. 2022. Nat Commun. 13:4539. PubMed
  359. Allard-Chamard H, et al. 2021. J Immunol. 206:524. PubMed
  360. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  361. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  362. Delgado-Gonzalez A, et al. 2022. STAR Protoc. 3:101425. PubMed
  363. Chou DB, et al. 2022. Nat Commun. 13:6021. PubMed
  364. Salahudeen AA, et al. 2020. bioRxiv. . PubMed
  365. Qi J, et al. 2021. Cell Reports Medicine. 2(8):100353. PubMed
  366. Hara T, et al. 2021. Cancer Cell. 39(6):779-792.e11. PubMed
  367. Clayton KL, et al. 2021. Cell Host Microbe. 29(3):435-447.e9. PubMed
  368. Nielsen S, et al. 2016. Nat Cell Biol. 18: 549-560. PubMed
  369. Jarantow S, et al. 2015. J Biol Chem. 290: 24689 - 24704. PubMed
  370. Anderson M, et al. 2014. Otolaryngology Head Neck Surg. 150:880. PubMed
  371. Sontheimer-Phelps A, et al. 2019. Cell Mol Gastroenterol Hepatol. 9:507. PubMed
  372. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  373. Cai Q, et al. 2019. Oncol Lett. 2.967361111. PubMed
  374. Yang ZZ, et al. 2019. Cell Rep. 26:2178. PubMed
  375. Olafsdottir TA, et al. 2022. Commun Biol. 5:914. PubMed
  376. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  377. Alhussan A, et al. 2022. Cancers (Basel). 14:. PubMed
  378. Lee PC, et al. 2022. J Clin Invest. 132:. PubMed
  379. Rouhani SJ, et al. 2022. J Immunother Cancer. 10:. PubMed
  380. Chan M, et al. 2021. Mol Syst Biol. 17:e10426. PubMed
  381. Rodríguez-Lorenzo S, et al. 2022. Elife. 11:. PubMed
  382. Vechetti IJ, et al. 2021. FASEB J. 35:e21644. PubMed
  383. Manríquez V, et al. 2021. Nat Commun. 12:4547. PubMed
  384. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  385. Pleguezuelos O, et al. 2015. Clin Vaccine Immunol. 22: 828 - 835. PubMed
  386. Alasoo K, et al. 2015. Sci Rep. 5: 12524. PubMed
  387. Burel J, et al. 2016. PLoS Pathog. 12: 1005839. PubMed
  388. MacBride M, et al. 2017. Mammalian Genome. 10.1007/s00335-017-9680-0. PubMed
  389. Chou DB, et al. 2020. Nat Biomed Eng. 0.440277778. PubMed
  390. Nistler R, et al. 2020. Immunohorizons. 0.397222222. PubMed
  391. Pettmann J, et al. 2021. eLife. 10:00. PubMed
  392. Luoma AM, et al. 2020. Cell. 182(3):655-671.e22. PubMed
  393. Perugino CA, et al. 2021. J Allergy Clin Immunol. 368:147. PubMed
  394. Lynskey N, et al. 2017. PLoS Pathog.. 10.1371/journal.ppat.1006493. PubMed
  395. Eitas T, et al. 2017. PLoS One. 10.1371/journal.pone.0184164. PubMed
  396. Verma SK, et al. 2018. J Biol Chem. 293:254. PubMed
  397. Shaw BC, et al. 2021. CRISPR J. 4:699. PubMed
  398. Chen C, et al. 2022. iScience. 25:103645. PubMed
  399. Lu J, et al. 2022. STAR Protoc. 3:101559. PubMed
  400. Ainsworth RI, et al. 2022. Nat Commun. 13:6221. PubMed
  401. Mpakou V, et al. 2021. Exp Ther Med. 1.010416667. PubMed
  402. Scharenberg SG, et al. 2020. Nat Commun. 2.76875. PubMed
  403. Sainson RCA, et al. 2020. Cancer Immunol Res. 1.422222222. PubMed
  404. Salahudeen AA, et al. 2020. Nature. 588:670. PubMed
  405. Okamura Y, et al. 2017. Allergol Int. 10.1016/j.alit.2017.03.002. PubMed
  406. An L, et al. 2016. Sci Rep. 6: 33346. PubMed
  407. Wolf J, et al. 2016. J Biol Chem. 291: 16186 - 16196. PubMed
  408. Schneck H, et al. 2015. PLoS One. 10: 0144535. PubMed
  409. Binnewies M, et al. 2019. Cell. 177:556. PubMed
  410. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  411. Itoh H, et al. 2017. J Vet Med. 10.1155/2017/5701016. PubMed
  412. Kamada R, et al. 2017. The Journal of Biochemistry. 10.1093/jb/mvx032. PubMed
  413. Yao W, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.04.017. PubMed
  414. Jeong HO, et al. 2022. iScience. 25:105358. PubMed
  415. Murphy DM, et al. 2022. J Clin Invest. Online ahead of print. PubMed
  416. Faissner S, et al. 2022. Front Immunol. 13:980526. PubMed
  417. Zha Y, et al. 2022. Front Immunol. 13:877314. PubMed
  418. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  419. Medeiros-Furquim T, et al. 2022. Front Immunol. 13:678817. PubMed
  420. Kaya-Tilki E, et al. 2021. PLoS One. 16:e0260633. PubMed
  421. Kämpe A, et al. 2021. PLoS One. 16:e0257442. PubMed
  422. Pinto SM, et al. 2021. Front Immunol. 12:679458. PubMed
  423. Chiou SH, et al. 2021. Immunity. 54:586. PubMed
  424. Wang EY, et al. 2021. Nature. 595:283. PubMed
RRID
AB_2818986 (BioLegend Cat. No. 422302)

Antigen Details

Molecular Family
Fc Receptors
Gene ID
NA

Related FAQs

Is our human Trustain FcX™ (cat# 422302) compatible with anti human CD16, CD32 and CD64 clones 3G8, FUN-2 and 10.1 respectively?

Yes

What is the concentration of Human TruStain FcX™ (Fc receptor blocking solution, Cat#422301)?
This information is proprietary.
Go To Top Version: 4    Revision Date: 07/14/2016

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account